Exercise Controls Tumor Cell Growth Through AMPK Activation

This study is currently recruiting participants. (see Contacts and Locations)
Verified November 2013 by Rigshospitalet, Denmark
Sponsor:
Information provided by (Responsible Party):
Inge Holm, Rigshospitalet, Denmark
ClinicalTrials.gov Identifier:
NCT01376583
First received: June 16, 2011
Last updated: November 28, 2013
Last verified: November 2013
  Purpose

The study investigates the explanation for the positive relation found between exercise and breastcancer.


Condition
Breast Cancer

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Running From Cancer

Resource links provided by NLM:


Further study details as provided by Rigshospitalet, Denmark:

Biospecimen Retention:   Samples Without DNA

Bloodsamples wherefrom, serum is isolated and kept at -20 degrees celsius


Estimated Enrollment: 10
Study Start Date: March 2011
Estimated Study Completion Date: December 2013
Estimated Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   18 Years to 30 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

Healthy Danish females in the age 18-30

Criteria

Inclusion Criteria:

  • Healthy Females age 18-30
  • BMI 18-25
  • Regular period

Exclusion Criteria:

  • Ingestions of any hormones
  • Pregnancy
  • Chronic inflammation
  • Elite athletes
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01376583

Locations
Denmark
Centre of Inflammation and Metabolism Recruiting
Copenhagen, Denmark, 2100
Contact: Grith W Højfeldt, BSc       grithwh@hotmail.com   
Principal Investigator: Grith W Højfeldt, BSc         
Sponsors and Collaborators
Rigshospitalet, Denmark
Investigators
Study Director: Bente K Pedersen, Professor Centre of Inflammation and Metabolism
  More Information

No publications provided

Responsible Party: Inge Holm, Administrator, Rigshospitalet, Denmark
ClinicalTrials.gov Identifier: NCT01376583     History of Changes
Other Study ID Numbers: VEK-H-3-2010-141
Study First Received: June 16, 2011
Last Updated: November 28, 2013
Health Authority: Denmark: Ethics Committee

Keywords provided by Rigshospitalet, Denmark:
Breast cancer
Exercise
Myokines
AMPK

Additional relevant MeSH terms:
Breast Neoplasms
Neoplasms by Site
Neoplasms
Breast Diseases
Skin Diseases

ClinicalTrials.gov processed this record on July 24, 2014